Models for analyzing data in initiation-promotion studies.

Trends in quantitative cancer risk assessment. Environ Health Perspect (1991) 0.75

Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest (1987) 1.82

A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis (1987) 1.15

A stochastic two-stage model for cancer risk assessment. II. The number and size of premalignant clones. Risk Anal (1989) 1.06

Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis. Cancer Res (1976) 1.02

Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis. Cancer Res (1979) 0.97

Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res (1984) 0.95

Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res (1986) 0.93

The rat liver foci bioassay: I. Age-dependence of induction by vinyl chloride of ATPase-deficient foci. Carcinogenesis (1985) 0.91

The early growth of cancer. J Math Biol (1985) 0.83

The rat liver foci bioassay: II. Investigations on the dose-dependent induction of ATPase-deficient foci by vinyl chloride at very low doses. Carcinogenesis (1985) 0.81

Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect (2000) 1.85

Nine steps to better nursing management of incontinence. Contemp Nurse (1995) 1.37

Guidelines for application of meta-analysis in environmental epidemiology. ISLI Risk Science Institute. Regul Toxicol Pharmacol (1995) 0.94

Epidemiology and risk assessment. Am J Epidemiol (1998) 0.91

Is ingested inorganic arsenic a "threshold" carcinogen? Fundam Appl Toxicol (1996) 0.83

Experience of mothers with early postnatal discharge: a study in progress. Int J Nurs Pract (1996) 0.78

How to choose: nurses' judgements of the effectiveness of a range of currently marketed continence aids. J Clin Nurs (1994) 0.75

The issue of critical paths in Australia: where are they taking us? Nurs Inq (1996) 0.75

The International Tissue and Tumor Repository for Chronic Arseniasis at the Armed Forces Institute of Pathology. Environ Health Perspect (2001) 0.75